Clinical Research
Clinical Trials in Abdominal Transplantation
Clinical trials within the Divison of Abdominal Transplantation include: Tolerance Induction, EVB-induced post-transplant lymphoma, and the following Stanford-based trials for liver, kidney, intestine, pacreas, diabetes, and hepatocellular carcinoma.
This page provides an auto-populated up-to-date list of Stanford Clinical Trials in: liver, kidney, intestine, pancreas, diabetes, hepatocellular carcinoma, and pediatric transplant.
-
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Stanford is currently accepting patients for this trial. -
Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients
Stanford is currently not accepting patients for this trial. -
On-Line Intervention to Lower Cardiovascular Risk in Pediatric Heart Transplant Patients
Stanford is currently not accepting patients for this trial. -
Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery
Stanford is currently not accepting patients for this trial. -
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
Stanford is currently not accepting patients for this trial. -
Immunotherapy Study for Surgically Resected Pancreatic Cancer
Stanford is currently not accepting patients for this trial. -
Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs.
Stanford is currently accepting patients for this trial. -
Diabetic Ketoacidosis and Its Impact on the Brain
Stanford is currently not accepting patients for this trial. -
Duration of Infusion Set Function: Quick-Set Teflon Catheter Versus Sure-T Steel Infusion Set Catheter
Stanford is currently not accepting patients for this trial. -
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
Stanford is currently not accepting patients for this trial. -
Glycemic Control and the Brain in Children With Type 1 Diabetes
Stanford is currently accepting patients for this trial. -
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
Stanford is currently not accepting patients for this trial. -
ATG-GCSF in New Onset Type 1 Diabetes
Stanford is currently accepting patients for this trial.